학술논문
Safety of PSMA-targeted molecular radioligand therapy with 177 Lu-PSMA-617: results from the prospective multicenter phase 2 trial RESIST-PC NCT03042312.
Document Type
Article
Author
Calais, Jeremie; Czernin, Johannes; Thin, Pan; Gartmann, Jeannine; Nguyen, Kathleen; Armstrong, Wesley R; Allen-Auerbach, Martin; Quon, Andrew; Bahri, Shadfar; Gupta, Pawan 5; Gardner, Linda; Dahlbom, Magnus; He, Beilei; Esfandiari, Rouzbeh; Ranganathan, David; Herrmann, Ken; Eiber, Matthias; Fendler, Wolfgang P.; Delpassand, Ebrahim
Source
Journal of Nuclear Medicine; Dec2021, Vol. 62 Issue 12, p1-30, 30p
Subject
Language
ISSN
01615505